Evidence review of the prognostic 40-gene expression profile test for cutaneous squamous cell carcinoma

Matthew Goldberg; Sarah Kurley; Jennifer Siegel; Alison Fitzgerald; Robert Cook

doi:10.25251/skin.6.supp.22

Matthew Goldberg

Castle Biosciences, Inc., Friendswood, TX

Sarah Kurley

Castle Biosciences, Inc., Friendswood, TX

Jennifer Siegel

Castle Biosciences, Inc., Friendswood, TX

Alison Fitzgerald

Castle Biosciences, Inc., Friendswood, TX

Robert Cook

Castle Biosciences, Inc., Friendswood, TX

Keywords

skin cancer

Abstract

N/A

References

1. Jambusaria-Pahlajani, et al. Arch Derm 2010

2. Farberg, et al. Dermatol Clinics 2017

3. Colomer et al. Clin Transl Oncol 2018

4. Plasseraud et al. J Oncol. 2016

5. Teplitz, et al JDD 2019

6. Litchman, et al CMRO 2020

7. Farberg, et al. in preparation

8. Wysong et al., JAAD 2021

9. Ibrahim, et al Future Oncology 2021

10. Borman et al. Diagn Pathol under review

11. Farberg et al. CMRO 2020

12. Aaron et al. JDD 2021

Poster PDF

Published

Mar 4, 2022

DOI https://doi.org/10.25251/skin.6.supp.22

How to Cite

Goldberg, M., Kurley, S., Siegel, J., Fitzgerald, A., & Cook, R. (2022). Evidence review of the prognostic 40-gene expression profile test for cutaneous squamous cell carcinoma. SKIN The Journal of Cutaneous Medicine, 6(2), s22. https://doi.org/10.25251/skin.6.supp.22

Issue

Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®)

Section

Skin Cancer

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by the following user license:

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

Sarah Estrada, Jeffrey Shackelton, Nathan Cleaver, Natalie Depcik-Smith, Clay Cockerell, Stephen Lencioni, Howard Martin, Jeffrey Wilkinson, Lauren Meldi Sholl, Michael Berg, Brooke Russell, Olga Zolochevska, Kyle Covington, Aaron Farberg, Matthew Goldberg, Pedram Gerami, Gregory Hosler, Development and Validation of a Diagnostic 35-Gene Expression Profile Test for Ambiguous or Difficult-to-Diagnose Suspicious Pigmented Skin Lesions , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®)
Aaron Farberg, Kelli Ahmed, Christine Bailey, Brooke Russell, Kelly Douglas, Clare Johnson, Olga Zolochevska, Robert Cook, Matthew Goldberg, A 35-Gene Expression Profile Test for use in Suspicious Pigmented Lesions Impacts Clinical Management Decisions of Dermatopathologists and Dermatologists , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®)
Eli Saleeby, Kenneth Bielinski, Alison Fitzgerald, Jennifer Siegel, Sherrif Ibrahim, A Prospective, Multi-Center Clinical Utility Study Demonstrates That the 40-Gene Expression Profile (40-GEP) Test Impacts Clinical Management for Medicare-Eligible Patients with High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference®
Matthew Goldberg, Jennifer Siegel, Brooke Russell, Jason Rogers, Kyle Covington, Kristen Oelschlanger, Trisha Poteet, Jeffrey Wilkinson , Michael Berg, Katherine Falkowski, Sarah Kurley, Armineh Kajoian, A comprehensive diagnostic offering workflow increases the rate of actionable results of the 23- and 35-gene expression profile tests for use as ancillary diagnostic tools for difficult-to-diagnose melanocytic lesions , SKIN The Journal of Cutaneous Medicine: Vol. 5 No. 6 (2021): November Issue & Poster Presentations (FC21 Dermatology Conference®)
Clay Cockerell, Matthew Goldberg, Sarah Estrada, Gregory Hosler, Howard Martin, Brooke Russell, Olga Zolochevska, Natalie Depcik-Smith, Nathan Cleaver, Performance of a 35-Gene Expression Profile Test in Suspicious Pigmented Lesions of the Head and Neck , SKIN The Journal of Cutaneous Medicine: Vol. 5 No. 1 (2021): January Issue & Poster Presentations (WC21 Dermatology Conference®)
Aaron Farberg, Jennifer Siegel, Briana Rackely , Alison Fitzgerald, Sarah Kurley, Robert Cook, Appropriate utilization of the prognostic 40-gene expression profile (40-GEP) test for cutaneous squamous cell carcinoma (cSCC) demonstrated by clinical reports and physician evaluation of real-world cases , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®)
Aaron Farberg, Matthew Goldberg, Ann Quick, Olga Zolochevska, Jeff Wilkinson, Jonathan Silverberg, Peter Lio, John Koo, Jeffrey Weinberg, Mark Lebwohl, Gene Expression Differences Identified in Skin Samples of Early-Stage Mycosis Fungoides, Atopic Dermatitis, and Psoriasis , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 6 (2023): November 2023 Issue
Lorrie-Beth Miley, Kelli Ahmed, Jennifer Siegel, Sonia Morgan-Linnell, Attitudes of Patients with Cutaneous Melanoma Towards Prognostic Testing Using Gene Expression Profiling , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®)
Christine Bailey, Brian Martin, Valentina Petkov, Jennifer Siegel, Sarah Kurley, Kyle Covington, 31-Gene Expression Profile Testing Survival Benefit in a Population-based Analysis of Cutaneous Melanoma Patients ≥65 Years of Age , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®)
Graham Litchman, Hilary Caruso, Robert Cook, Darrell Rigel, Recurrence prediction in cutaneous melanoma with 31-gene expression profiling and sentinel lymph node biopsy , SKIN The Journal of Cutaneous Medicine: Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas

1 2 > >>

Main Article Content

Keywords

Abstract

References

Article Sidebar

Article Details

Similar Articles

Most read articles by the same author(s)